Trial Profile
Telbivudine versus Entecavir in Patients with Chronic Hepatitis B: 2-Year Results of a Head-To-Head Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2014
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 31 Mar 2014 New trial record